Skip to main content

Editas CEO to testify at U.S. Senate hearing on gene editing potential, ethics

The hearing, titled “Gene Editing Technology: Innovation and Impact,” will also feature testimony from a Stanford University scientist and a bioethicist at Johns Hopkins University.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.